Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

TVTXTVTX
23 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in TRAVERE THERAPEUTICS INC

Yes. Geode Capital Management holds 2,371,887 shares of TVTX (Travere Therapeutics), worth $134.8M, as of its Q2 2026 13F filing. It increased the position by 2,328 shares (+0.1%) from Q1 2026. Geode Capital Management has held TVTX in every 13F on record since Q4 2020, 23 quarterly filings.

Current Value

$134.8M

Current Shares

2.4M

Total Value Change

+$114.1M

Total Shares Change

+1.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.4M
+0.1%
$134.8M0.0%$56.81
30
2026-Q1
Increased
2.4M
+10.6%
$70.4M0.0%$29.71
33
2025-Q4
Increased
2.1M
+0.3%
$81.9M0.0%$38.21
30
2025-Q3
Increased
2.1M
+6.7%
$51.1M0.0%$23.90
31
2025-Q2
Increased
2M
+1.4%
$29.7M0.0%$14.80
29
2025-Q1
Increased
2M
+7.3%
$35.4M0.0%$17.92
31
2024-Q4
Increased
1.8M
+6.4%
$32.1M0.0%$17.42
31
2024-Q3
Increased
1.7M
+3.9%
$24.2M0.0%$13.99
30
2024-Q2
Increased
1.7M
+6.8%
$13.7M0.0%$8.22
30
2024-Q1
Increased
1.6M
+2.6%
$12M0.0%$7.71
29
2023-Q4
Increased
1.5M
+5.6%
$13.7M0.0%$8.99
30
2023-Q3
Increased
1.4M
+3.5%
$12.9M0.0%$8.94
29
2023-Q2
Increased
1.4M
+14.4%
$21.4M0.0%$15.36
32
2023-Q1
Increased
1.2M
+10.9%
$27.4M0.0%$22.49
32
2022-Q4
Increased
1.1M
+3.5%
$23.1M0.0%$21.03
30
2022-Q3
Increased
1.1M
+3.5%
$26.1M0.0%$24.64
30
2022-Q2
Decreased
1M
-3.2%
$24.8M0.0%$24.23
0
2022-Q1
Increased
1.1M
+1.5%
$27.3M0.0%$25.77
29
2021-Q4
Increased
1M
+6.0%
$32.4M0.0%$31.04
31
2021-Q3
Decreased
983,978
-2.1%
$23.9M0.0%$24.25
0
2021-Q2
Increased
1M
+5.0%
$14.7M0.0%$14.59
30
2021-Q1
Increased
957,246
+26.3%
$23.9M0.0%$24.97
35
2020-Q4
New
757,861
-
$20.7M0.0%$27.26
39

Other major holders of TVTX: Jupiter Topco LLC, BlackRock, Inc., FMR LLC, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used